Turkey: A further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 2, 2008, Pages 284-288

  Yumuk, Zeki ^a   Afacan, Gokhan ^b   Nicolas Chanoine, Marie Hélène ^c   Sotto, Albert ^c   Lavigne, Jean Philippe ^c,d  

^a KOCAELI UNIVERSITY   (Turkey)

^b Hifzissihha Institute   (Turkey)

^c INSERM   (France)

^d DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Enterobacteria; Epidemiology; Extended spectrum lactamases

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M 15; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ESCHERICHIA COLI PROTEIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NETILMICIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ASIAN; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; COMMUNICABLE DISEASE; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI O25 ST131; FEMALE; GENE CLUSTER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NURSING HOME; PHYLOGENY; PROSPECTIVE STUDY; SEROTYPE; TURKEY (REPUBLIC); URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHYLOGENY; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; TURKEY; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 47249091453     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn181     Document Type: Article

References (10)

1. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-75.
2. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
3. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
4. Ho PL, Poon WW, Loke SL et al. Community emergence of CTX-M type extended-spectrum β-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 2007; 60: 140-4.
5. Gonullu N, Aktas Z, Kayacan CB et al. Dissemination of CTX-M-15 β-lactamase genes carried on Inc F1 and 11 plasmids among clinical isolates of Escherichia coli in a University Hospital in Istanbul, Turkey. J Clin Microbiol 2008; 46: 1110-2.
6. Cattoir V, Poirel L, Rotimi V et al. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007; 60: 394-7.
7. Lavigne JP, Marchandin H, Delmas J et al. qnrA in CTX-M-producing Escherichia coli from France. Antimicrob Agents Chemother 2006; 50: 4224-8.
8. Clermont O, Johnson JR, Menard M et al. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: Application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 2007; 57: 129-36.
9. Pallecchi L, Bartoloni A, Fiorelli C et al. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007; 51 2720-5.
10. Karisik E, Ellington MJ, Livermore DM et al. Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2008; 61: 54-8.